Greenwich LifeSciences (GLSI)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	5.82 mm	5.82 mm	5.82 mm	5.82 mm	5.82 mm	5.82 mm
Cash burn (monthly)	467.50 k	276.77 k	909.68 k	896.97 k	861.31 k	630.71 k
Cash used (since last report)	1.32 mm	779.35 k	2.56 mm	2.53 mm	2.43 mm	1.78 mm
Cash remaining	4.51 mm	5.04 mm	3.26 mm	3.30 mm	3.40 mm	4.05 mm
Runway (months of cash)	9.6	18.2	3.6	3.7	3.9	6.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

GLSI institutional ownership history Ownership history

4.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	16	29	-44.8%
Opened positions	9	24	-62.5%
Closed positions	22	1	+2100.0%
Increased positions	3	0	NEW
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	2.18 bn	10.20 bn	-78.6%
Total shares	563.40 k	993.70 k	-43.3%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Weiner Michael Guy	429.69 k	$9.35 mm	0.0%
STT State Street	68.40 k	$1.18 bn	+426.1%
Man Group Limited	16.65 k	$287.38 mm	NEW
BK The Bank of New York Mellon Corporation	15.30 k	$263.99 mm	NEW
MS Morgan Stanley	7.05 k	$121.74 mm	+13.2%
Rhumbline Advisers	6.80 k	$117.35 mm	NEW
BAC Bank of America	6.33 k	$109.22 mm	NEW
New York State Common Retirement Fund	6.00 k	$104.00 k	NEW
CRBG Corebridge Financial	3.21 k	$55.47 mm	NEW
BCS Barclays	2.02 k	$35.00 k	NEW

Largest transactions	Shares	Bought/sold	Change
Vanguard	0.00	-223.10 k	EXIT
Geode Capital Management	0.00	-58.24 k	EXIT
BLK BlackRock	0.00	-56.46 k	EXIT
STT State Street	68.40 k	+55.40 k	+426.1%
GS The Goldman Sachs Group, Inc.	0.00	-41.51 k	EXIT
Renaissance Technologies	0.00	-37.50 k	EXIT
Susquehanna International	0.00	-35.87 k	EXIT
NTRS Northern Trust	0.00	-21.22 k	EXIT
Jane Street	0.00	-20.64 k	EXIT
Qube Research & Technologies	0.00	-17.32 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

GLSI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
21 Nov 24	Jaye Thompson	Common Stock	Buy	Acquire P	No	No	12.91	1,000	12.91 k	264,148
26 Sep 24	Snehal Patel	Common Stock	Buy	Acquire P	No	No	14.63	1,500	21.95 k	5,536,102
12 Aug 24	Jaye Thompson	Common Stock	Buy	Acquire P	No	No	13.85	800	11.08 k	263,148
23 Jul 24	Snehal Patel	Common Stock	Buy	Acquire P	No	No	15.89	1,500	23.84 k	5,527,102
18 Jul 24	Jaye Thompson	Common Stock	Buy	Acquire P	No	No	16	1,000	16.00 k	261,348

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Greenwich LifeSciences Partners with GIM in Italy

26 Nov 24

STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,

Greenwich LifeSciences Provides Update on Corporate Events

18 Nov 24

STAFFORD, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy